Inhibition of the Mevalonate Pathway Targets Neuroblastoma Stem Cells

Researchers observed the use of mevalonate pathway inhibitors against the CSC population of high-risk neuroblastoma cell lines SH-SY5Y, SK-N-AS, and SK-N-BE(2)-C using spheroid-based assays.